My Profile e-Learning Center my.ASTHO Contact Us

Displaying 2 results for

Search Filters: Policy cancel Data Modernization and Informatics cancel Massachusetts cancel

2023 Legislative Session Update: Part Two

Blog,
Health Policy Update,
Policy,
State Health Policy,
Public Health Law,
Population Health and Prevention,
Women, Infant, and Family Health,
Contraception Access,
Women, Infant, Family Health Data Integration,
Data Modernization and Informatics,
Health Equity,
Infectious Disease,
Immunization,
Public Health Workforce,
Public Health Infrastructure and Systems Improvement,
California,
Connecticut,
Indiana,
Iowa,
Maine,
Maryland,
Massachusetts,
Missouri,
Montana,
New Jersey,
New York,
Oklahoma,
Rhode Island,
Texas,
Vermont,
Washington,
Maggie Davis,
Andy Baker-White,
Lillian Colasurdo,
Lana McKinney

A mid-session legislative update on five of ASTHO's top 10 public health state policy issues to watch in 2023: data privacy and modernization, reproductive health, health equity, strengthening public health agencies, and immunization.

Neonatal Abstinence Syndrome: State Considerations for 2021

Blog,
Health Policy Update,
Population Health and Prevention,
Women, Infant, and Family Health,
Risk-Appropriate Care,
Social and Behavioral Health,
Substance Misuse,
Opioids,
Overdose Prevention,
Policy,
State Health Policy,
Early Brain Development,
Delaware,
Massachusetts,
New Hampshire,
New York,
Oklahoma,
Beth Giambrone,
Health Care Access,
Federal Government Affairs,
Data Modernization and Informatics,
Public Health Infrastructure and Systems Improvement

Neonatal Abstinence Syndrome (NAS) has become more prevalent in the United States, with the hospitalization rate increasing from 2.9 to 7.3 hospitalizations per 1,000 newborn births between 2009 and 2017. NAS occurs in newborns who experience withdrawal from substances they were exposed to during pregnancy. While NAS is most often associated with exposure to opioids (e.g., Neonatal Opioid Withdrawal Syndrome), it can also be caused by exposure to other drugs such as cocaine, amphetamines, or barbiturates. Infants with NAS experience withdrawal symptoms including tremors, irritability, poor feeding, vomiting, dehydration, and increased sweating. These symptoms usually appear within 72 hours of birth.